Tuberculosis, Multidrug-Resistant Clinical Trials

40 clinical trials for Tuberculosis, Multidrug-Resistant across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Training Protocol on the Natural History of Tuberculosis — RECRUITING
• Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis — RECRUITING · PHASE2
• Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB — RECRUITING · PHASE2
• A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients — RECRUITING · PHASE3
• Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia — RECRUITING
• Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB — ACTIVE_NOT_RECRUITING · PHASE2
• Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis — NOT_YET_RECRUITING · NA
• Linezolid Dosing Strategies in Drug-Resistant TB — COMPLETED · PHASE2
• Bioneer Q-RFIA Clinical Evaluation — ACTIVE_NOT_RECRUITING
• Study of TB Lesions Obtained in Therapeutical Surgery — COMPLETED
• Evaluating Newly Approved Drugs for Multidrug-resistant TB — COMPLETED · PHASE3
• Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) — COMPLETED · PHASE3
• An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) — COMPLETED · PHASE2
• A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis — COMPLETED · PHASE2
• Treatment Shortening of MDR-TB Using Existing and New Drugs — COMPLETED · PHASE2
• Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens — OTHER
• Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry) — NOT_YET_RECRUITING
• Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) — COMPLETED · PHASE2
• Nosocomial Transmission of MDR-TB in Bucharest, Romania — COMPLETED
• Biomarkers for Therapy Response in Drug-resistant Tuberculosis — COMPLETED
• Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients — COMPLETED · PHASE2
• PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis — TERMINATED · NA
• Clinical Evaluation of tNGS for Diagnosis of DR-TB — COMPLETED
• The Individualized M(X) Drug-resistant TB Treatment Strategy Study — TERMINATED · PHASE4
• Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis — COMPLETED · PHASE3
• Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB — COMPLETED · PHASE2
• Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis — OTHER · PHASE2
• DIAgnostics for Multidrug Resistant Tuberculosis in Africa — COMPLETED
• A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China — OTHER · PHASE4
• Safety of RUTI® Vaccination in MDR-TB Patients — TERMINATED · PHASE2
• Expand New Drugs for TB [endTB] — COMPLETED
• A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) — COMPLETED · PHASE2
• A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683 — COMPLETED · PHASE2
• Xpert MTB/XDR Clinical Evaluation Trial — COMPLETED
• Drug Concentrations in the Treatment of MDR-TB Related to Minimum Inhibitory Concentrations — COMPLETED
• Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients — OTHER
• Tuberculosis in China — COMPLETED
• Operational Assessment of Laboratory Information System for MDR-TB in Lima, Peru — COMPLETED
• Global Consortium for Drug-resistant Tuberculosis Diagnostics — COMPLETED
• High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis — COMPLETED · PHASE2

Refine this search